Sell Your Science - Best Practices for Developing an Effective Non-Confidential Pitch Deck

Jan 20 2016

It can be tricky to communicate the full potential of your discoveries without spilling the secret sauce. Join us every other week for sessions on learning the tricks of the trade in preparing a non-confidential deck and executive summary. Experts of the craft will share practical tips on becoming more effective in communicating your story to Angel investors and VCs, increasing your chances of successful fundraising.

Dan Watkins | Co-founder, Mercury Fund read bio»

11:30 AM | Registration, Networking and Lunch*
12:00 PM | Presentation
12:45 PM | Q&A
1:00 PM | Program Close

*Light food & beverage provided

Who should attend:
This workshop is ideal for inventors in academic centers and hospitals, and early stage healthcare start-ups in the pharma, medical device, consumer health and digital innovation areas.

There is no cost to attend this workshop, but pre-registration is required.

Texas Medical Center Innovation Institute, TMCx
John P. McGovern Campus
2450 Holcombe Blvd.
Houston, TX 77021

Parking Information:
Please park in the self parking areas of the McGovern Campus. Grab a Token at the gate and bring it to the event space. We encourage carpooling and using the TMC shuttles.

Speaker's Biography:
Dan Watkins, Ph.D. | Co-founder, Mercury Fund
Dan Watkins is a co-founder of Mercury Fund where he leads the Sciences team. He focuses on both Physical and Life Sciences startups, many at the formation or university spinoff stage. Prior to Mercury, Dan served in a number of operational roles including initial CEO of DNAtrix, Courier Therapeutics and Nanospectra Biosciences. Previously, Dan held the roles of Vice President at a boutique investment banking firm and Worldwide Manager of Operations Control Systems for Scientific Software-Intercomp (Baker Hughes). Dan currently serves on the board of directors of a number of life sciences companies including: DNAtrix, GlycosBio (industrial biotechnology), Swift Biosciences (next generation sequencing), Sinopsys Surgical (medical device) and Resonant Therapeutics (novel antibody discovery) and Courier Therapeutics (immunotherapy). Dan received a B.S. from Rice University and a M.S. and Ph.D. from Carnegie Mellon University, all in Materials Science. Outside of Mercury, Dan serves on the advisory boards of Northwestern University's Innovation and New Ventures Office (INVO), the University of Michigan's Venture Center Council, and BioHouston. Dan is also the co-founder of the Rice Alliance for Technology and Entrepreneurship at Rice University.